GlassScriptPhysician profile
Debra K Michel
NPI 1326040015
$3,616.50
in general payments reported to CMS, 2019-2025
18 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $604 · 2021: $1,447 · 2022: $351 · 2023: $182 · 2024: $76.43 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.03 | 2019-2025 | |
| Amgen INC. | $704.85 | 2019-2023 | |
| Pfizer INC. | $321.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $236.06 | 2019-2024 | |
| Horizon Therapeutics Plc | $219.04 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $199.34 | 2021-2023 | Saphnelo |
| Lilly USA, LLC | $197.15 | 2019-2022 | |
| Janssen Biotech, INC. | $193.35 | 2020-2025 | Tremfya, Simponi Aria |
| Glaxosmithkline, LLC. | $177.65 | 2020-2025 | Nucala |
| Janssen Pharmaceuticals, INC | $111.44 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $108.84 | 2022 | |
| Genentech USA, INC. | $104.46 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $95.89 | 2020-2021 | |
| Radius Health, INC. | $55.18 | 2021 | |
| Sobi, INC | $49.28 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $45.14 | 2022 | |
| Ucb, INC. | $33.71 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Michel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.